Circ Cardiovasc Interv

Slides:

Advertisements

Similar presentations

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Renal Denervation on 24-Hour Ambulatory.

Advertisements

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Aspirin Administered at Bedtime, But Not on Awakening,

Renal Artery Angioplasty and Stenting: Optimal Patient Selection

Severity of Coronary Arterial Stenoses Responsible for Acute Coronary Syndromes Ganesh Manoharan, MD, Argyrios Ntalianis, MD, Olivier Muller, MD, PhD,

Copyright © 2010 American Medical Association. All rights reserved.

Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review

Copyright © 2011 American Medical Association. All rights reserved.

CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.

Renal Artery Angioplasty and Stenting

Renal Artery Stenosis: When to Revascularize in 2017

Modeling Hemodynamic Profiles by Telemetry in the Rat

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

The left panel shows a schematized left ventricular (LV) pressure–volume loop from a patient with primary systolic failure. A normal LV pressure–volume.

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Renal Denervation as a Therapeutic Approach for Hypertension

Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.

Case of nonobstructive coronary artery disease of left anterior descending artery (LAD) and regional LV dysfunction detected on cardiac CT with subsequent.

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Quantitative Coronary Angiogram Analysis

Circ Cardiovasc Interv

Energy Loss Index in Aortic Stenosis

Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing.

Circ Cardiovasc Qual Outcomes

Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated CardiomyopathyClinical Perspective by Diane Fatkin, Thomas.

Optima DES system: The stent has multiple grooves (reservoirs) on its abluminal surface into which the drug is loaded. Optima DES system: The stent has.

Circ Cardiovasc Interv

by Katie Ayers, Loretta M. Byrne, Anthony DeMatteo, and Nancy J. Brown

Circ Cardiovasc Qual Outcomes

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Physician and Patient Influences on Provider Performance

Circ Cardiovasc Interv

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Patent Foramen Ovale Closure in Obstructive Sleep Apnea Improves Blood Pressure and Cardiovascular FunctionNovelty and Significance by Stefano F. Rimoldi,

Effect of Provider Volume on the Accuracy of Hospital Report Cards

New Frontiers in Cardiology

Diets Containing Pistachios Reduce Systolic Blood Pressure and Peripheral Vascular Responses to Stress in Adults With DyslipidemiaNovelty and Significance.

Box plot showing percentage change in early diastolic pulsed-Doppler mitral inflow (E)/early diastolic tissue Doppler velocity (E´) from pre– to post–balloon.

Supravalvular Aortic Stenosis

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

by Nick E. J. West, Peter N. Ruygrok, Clemens M. C. Disco, Mark W. I

Circ Cardiovasc Interv

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

Effect of intervention on diastolic function.

Mathematical representation of Bayes theorem.

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

Pulse Pressure and Resistance Artery Structure in the Elderly

by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Blood Pressure Rhythmicity and Visceral Fat in Children With HypertensionNovelty and Significance by Anna Niemirska, Mieczysław Litwin, Janusz Feber, and.

Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.

Resistant Hypertension: Initial Combinations of Medications

Lack of Blood Pressure-lowering Effect of Renal Denervation in a Drug-naïve Patient with Pronounced Arterial Stiffening Robert von Arx, MD, Emrush Rexhaj,

The Need for Randomized Trials to Prove the Safety and Efficacy of Parachutes, Bulletproof Vests, and Percutaneous Renal Intervention Christopher J.

Chapter 28 Nutrition, Lifestyle, and Hypertension

Plot of average differences in arterial blood pressure using the two methods in mm Hg against both methods for systolic blood pressure (A) and diastolic.

Blood Pressure and Mean Arterial Pressure

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Assessment of pulse transit time to indicate cardiovascular changes during obstetric spinal anaesthesia† G Sharwood-Smith, J Bruce, G Drummond British.

Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

Circ Cardiovasc Interv Translesional Pressure Gradients to Predict Blood Pressure Response After Renal Artery Stenting in Patients With Renovascular HypertensionClinical Perspective by Fabio Mangiacapra, Catalina Trana, Giovanna Sarno, Giedrius Davidavicius, Marcin Protasiewicz, Olivier Muller, Argyrios Ntalianis, Nerijus Misonis, Bruno Van Vlem, Guy R. Heyndrickx, and Bernard De Bruyne Circ Cardiovasc Interv Volume 3(6):537-542 December 14, 2010 Copyright © American Heart Association, Inc. All rights reserved.

Average blood pressure value as recorded by 24-hour monitoring at baseline and at 3-month follow-up. Fabio Mangiacapra et al. Circ Cardiovasc Interv. 2010;3:537-542 Copyright © American Heart Association, Inc. All rights reserved.

Systolic and diastolic blood pressure changes as recorded by a 24-hour arterial blood pressure monitoring during the follow-up period. Systolic and diastolic blood pressure changes as recorded by a 24-hour arterial blood pressure monitoring during the follow-up period. Fabio Mangiacapra et al. Circ Cardiovasc Interv. 2010;3:537-542 Copyright © American Heart Association, Inc. All rights reserved.

Sensitivity/specificity curves of baseline mean gradient, papaverine-induced mean gradient, and dopamine-induced mean gradient to predict a favorable response of hypertension after renal stenting for RAS. Solid line indicates the optimal cutoff point to predict a favorable response. Sensitivity/specificity curves of baseline mean gradient, papaverine-induced mean gradient, and dopamine-induced mean gradient to predict a favorable response of hypertension after renal stenting for RAS. Solid line indicates the optimal cutoff point to predict a favorable response. Dashed line indicates the point that is 95% predictive of a favorable response. Fabio Mangiacapra et al. Circ Cardiovasc Interv. 2010;3:537-542 Copyright © American Heart Association, Inc. All rights reserved.

Correlation between translesional pressure gradients and percent DS at quantitative angiography. Fabio Mangiacapra et al. Circ Cardiovasc Interv. 2010;3:537-542 Copyright © American Heart Association, Inc. All rights reserved.